Suggestions
Bruno Strigini
Chairman of the board
Bruno Strigini is a seasoned healthcare executive with over 30 years of experience in the pharmaceutical industry. He currently serves as a director at Neopharmed Gentili S.P.A. and has held several prominent positions throughout his career.
Professional Background
-
CEO of Novartis Oncology (2014-2018): Strigini led a global team of over 10,000 associates across 85 countries, focusing on innovative cancer care solutions.
-
President of Europe/Canada at Merck & Co.: Prior to his role at Novartis, he was responsible for operations in Europe and Canada.
-
Experience with Other Major Companies: Strigini has held various leadership roles at Schering-Plough, UCB, and SmithKline Beecham, where he was involved in international operations and marketing.
Current Roles
In addition to his directorship at Neopharmed Gentili, Strigini is also:
- Chairman of the Board at Owkin: An AI and machine learning company specializing in healthcare.
- Director at Neuraxpharm: A European specialty pharmaceutical company focused on CNS treatments.
- Partner at OneHealth Partners: An advisory firm in healthcare.
Education and Honors
Bruno Strigini holds multiple degrees, including:
- MBA from IMD Lausanne, Switzerland
- PharmD from the University of Montpellier, France
- Master’s degree in Microbiology from Heriot-Watt University, UK
He is a member of the French Academy of Pharmacy and received an honorary doctorate from the Universidad Internacional Menéndez Pelayo in Spain in 2014.12
